
- Ophthalmology Times: October 15, 2020
- Volume 45
- Issue 17
Rejuvenation of outflow system: The time has come for procedure
Goniotomy-viscodilation cataract surgery controls IOP without medications.
A hybrid minimally invasive
“The trabecular meshwork and collector channels are the conventional outflow pathway that is responsible for at least 50% of outflow resistance,” said Linda Burk, MD, clinical professor of ophthalmology at the University of Texas Southwestern Medical School in Dallas. “The question is: Can this pathway be rejuvenated?”
Related:
Parallel decisions
During consideration of an improved procedure, she described that the Kahook Dual Blade (New World Medical) can cut parallel incisions, minimize collateral damage, and does not leave trabecular meshwork leaflets in its wake that can lead to fibrosis.
Burk noted that her previous trabecular meshwork specimens were characterized by loss of cells and collagen deposits.
Burk’s search for the improved procedure led to the combination procedure that included removal of the trabecular meshwork with use of the Kahook Dual Blade, which resulted in direct viscodilation of the collector channels and decreased hyphemas.
Innovative technique
In this innovative technique, Burk uses the dual blade to “glide along” Schlemm’s canal to remove the trabecular meshwork.
She adjusts the lens to open more of the canal. Generally, the trabecular meshwork comes out on the dual blade. Healon is injected to define the canal by holding the cannula snuggly against the back wall as more Healon is injected.
At this point, Schlemm’s canal is now a “clean gutter.” The anterior chamber Healon and any residual debris then is removed.
Related:
She explained that lowering the intraocular pressure (IOP) allows blood to backflow into the anterior chamber and demonstrate that Schlemm’s canal is open.
Filling the anterior chamber with balanced saline solution shows the episcleral fluid wave.
Burk reported the 18-months results of this procedure in 120 eyes 1 year after the procedure. Half of the patients had moderate to severe
The mean baseline IOP of 18.8 mm Hg decreased to 16.2 mm Hg at 18 months; 85% of patients achieved this result without the use of medications.
The results showed that 94% had an IOP of 21 mm Hg or lower, and 42% had 15 mm Hg or lower. The reduction in the overall use of medications was significant, with a saving of $84,000 in the first year, according to Burk.
Related:
“Even patients with advanced
An advantage of the procedure under discussion is that it is repeatable, which was done in 4 eyes at 15 months after the initial procedure and then again 8 months later. Three of the patients did not require medications at 2 years.
Conclusion
Burk concluded that combined goniotomy and viscodilation allows access to diseased tissue by removing the trabecular meshwork and access to and viscodilation of multiple connector channels.
“Goniotomy is easily combined with
---
Linda Burk, MD
e: [email protected]
Burk has no financial interest in this subject matter.
Articles in this issue
almost 5 years ago
Study: Some RP abnormalities are linked with lower visual acuityalmost 5 years ago
Teleretinal screening: Effective, less costly option for DRalmost 5 years ago
Investigators challenge IOL power calculationsalmost 5 years ago
The history of progress and innovation in cataract surgeryalmost 5 years ago
ICLs: Investigators finding robust and stable results over long termalmost 5 years ago
Exploring four decades of change in retinaalmost 5 years ago
Glaucoma 45 years later: Much changed, much unchangedalmost 5 years ago
Celebrating a pivotal moment in laser-vision correction historyalmost 5 years ago
Deep learning algorithm proven accurate for AMD classificationalmost 5 years ago
Long-acting prostaglandin implant creating shift in IOP-lowering therapyNewsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.